Beyond Air, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Beyond Air, Inc. (XAIR) on August 18, 2020, reporting an event that occurred on August 12, 2020. The Company is an emerging growth company incorporated in Delaware, with its principal executive office in Garden City, NY.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a contractual agreement rather than financial performance results.
Material Changes
On August 12, 2020, the Company entered into a Material Definitive Agreement (Item 1.01) with Medisize Ireland Limited. The agreement engages the Seller to manufacture and assemble certain components of the Company's LungFit system. Prices and specifications are to be determined via statements of work.
Outlook, Risks, and Unusual Items
- Agreement Terms: The initial term is three years with automatic one-year renewals unless terminated.
- Termination Rights: The agreement may be terminated by mutual agreement, by either party for any reason with six months' notice, or for breach if not cured within a 30-day notice period.
- Exhibits: The Manufacture and Supply Agreement is filed as Exhibit 10.1, though certain portions were omitted.
Key Facts for Investor Verification
- Verify the specific pricing and volume commitments in the statements of work referenced in the agreement.
- Confirm the impact of this manufacturing partnership on the Company's production capacity and cost structure for the LungFit system.
- Review the omitted portions of Exhibit 10.1 to understand any confidential commercial terms.